Last reviewed · How we verify
Placebo via DISKUS — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo via DISKUS (Placebo via DISKUS) — GlaxoSmithKline. Placebo produces no pharmacological effect and serves as an inert control in clinical trials and research studies.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo via DISKUS TARGET | Placebo via DISKUS | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo via DISKUS CI watch — RSS
- Placebo via DISKUS CI watch — Atom
- Placebo via DISKUS CI watch — JSON
- Placebo via DISKUS alone — RSS
Cite this brief
Drug Landscape (2026). Placebo via DISKUS — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-via-diskus. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing